HIV Treatment: MK-4646 Study

We are testing a new medication, MK-4646, for people living with HIV. The study aims to see how well it works in managing the virus compared to current treatments.

6-12 monthsSafety phase (I)Infectious Diseases

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institutul National De Boli Infectioase Prof.Dr.Matei Bals
Institutul National De Boli Infectioase Prof.Dr.Matei Bals ‘Phase I Unit: Pavilion 1, Wards 2,3,4'
Bucharest, Romania
Sponsor: Merck Sharp & Dohme LLC
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.